See more : Cannabix Technologies Inc. (BLOZF) Income Statement Analysis – Financial Results
Complete financial analysis of Innospec Inc. (IOSP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Innospec Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Gander Gold Corporation (GAND.CN) Income Statement Analysis – Financial Results
- Etsy, Inc. (3E2.F) Income Statement Analysis – Financial Results
- Mirgor Sociedad Anónima, Comercial, Industrial, Financiera, Inmobiliaria y Agropecuaria (MIRG.BA) Income Statement Analysis – Financial Results
- Caisse Régionale de Crédit Agricole du Morbihan (CMO.PA) Income Statement Analysis – Financial Results
- HERBAL DISPATCH INC. (LUFFF) Income Statement Analysis – Financial Results
Innospec Inc. (IOSP)
About Innospec Inc.
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.95B | 1.96B | 1.48B | 1.19B | 1.51B | 1.48B | 1.31B | 883.40M | 1.01B | 960.90M | 818.80M | 776.40M | 774.40M | 683.20M | 598.50M | 640.50M | 602.40M | 532.10M | 527.70M | 480.50M | 462.20M | 451.50M | 420.90M | 422.40M | 516.80M | 465.00M |
| Cost of Revenue | 1.36B | 1.38B | 1.05B | 850.40M | 1.05B | 1.04B | 903.50M | 551.10M | 666.30M | 658.90M | 563.60M | 540.00M | 548.00M | 466.00M | 409.20M | 454.10M | 405.00M | 345.40M | 338.20M | 271.00M | 257.70M | 257.30M | 240.20M | 238.90M | 309.90M | 227.20M |
| Gross Profit | 591.10M | 586.70M | 434.90M | 342.70M | 466.20M | 435.00M | 403.30M | 332.30M | 346.00M | 302.00M | 255.20M | 236.40M | 226.40M | 217.20M | 189.30M | 186.40M | 197.40M | 186.70M | 189.50M | 209.50M | 204.50M | 194.20M | 180.70M | 183.50M | 206.90M | 237.80M |
| Gross Profit Ratio | 30.33% | 29.88% | 29.32% | 28.72% | 30.81% | 29.45% | 30.86% | 37.62% | 34.18% | 31.43% | 31.17% | 30.45% | 29.24% | 31.79% | 31.63% | 29.10% | 32.77% | 35.09% | 35.91% | 43.60% | 44.24% | 43.01% | 42.93% | 43.44% | 40.03% | 51.14% |
| Research & Development | 41.70M | 38.70M | 37.40M | 30.90M | 35.40M | 33.40M | 31.40M | 25.40M | 25.30M | 22.20M | 21.20M | 19.60M | 18.30M | 17.60M | 16.40M | 14.80M | 13.60M | 11.10M | 11.20M | 10.50M | 5.10M | 6.00M | 5.10M | 3.10M | 3.90M | 3.10M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 387.80M | 360.70M | 267.20M | 237.00M | 280.90M | 261.00M | 239.50M | 209.50M | 206.70M | 169.20M | 141.90M | 117.10M | 155.90M | 111.90M | 142.50M | 115.20M | 103.90M | 99.00M | 97.60M | 93.40M | 75.70M | 70.00M | 57.60M | 41.50M | 44.90M | 40.10M |
| Other Expenses | 0.00 | -1.60M | 3.80M | 7.80M | 5.30M | 5.00M | 6.60M | 900.00K | 0.00 | 1.80M | 4.10M | -2.00M | 0.00 | 4.60M | 4.70M | 7.00M | 29.00M | 40.20M | 147.10M | 56.30M | 10.40M | -6.30M | -103.93M | 80.20M | 68.40M | 59.70M |
| Operating Expenses | 429.50M | 399.40M | 304.60M | 267.90M | 316.30M | 294.40M | 270.90M | 234.90M | 232.00M | 191.40M | 163.10M | 136.70M | 174.20M | 134.10M | 163.60M | 137.00M | 146.50M | 150.30M | 255.90M | 160.20M | 91.20M | 69.70M | -41.23M | 124.80M | 117.20M | 102.90M |
| Cost & Expenses | 1.79B | 1.78B | 1.35B | 1.12B | 1.36B | 1.34B | 1.17B | 786.00M | 898.30M | 850.30M | 726.70M | 676.70M | 722.20M | 600.10M | 572.80M | 591.10M | 551.50M | 495.70M | 594.10M | 431.20M | 348.90M | 327.00M | 198.97M | 363.70M | 427.10M | 330.10M |
| Interest Income | 2.30M | 1.10M | 1.50M | 1.80M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 400.00K | 400.00K | 600.00K | 600.00K | 500.00K | 300.00K | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 1.10M | 1.50M | 1.80M | 4.80M | 6.90M | 8.20M | 3.20M | 4.00M | 3.40M | 2.30M | 1.80M | 3.30M | 4.60M | 6.00M | 6.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 39.30M | 45.00M | 46.20M | 50.70M | 51.00M | 55.70M | 55.60M | 37.70M | 35.20M | 29.10M | 20.40M | 11.50M | 14.40M | 15.40M | 18.40M | 23.00M | 31.30M | 27.40M | 28.70M | 24.40M | 25.80M | 32.40M | 87.20M | 80.20M | 68.40M | 59.70M |
| EBITDA | 200.90M | 187.30M | 182.10M | 92.20M | 206.20M | 194.20M | 191.90M | 144.00M | 156.30M | 143.40M | 115.10M | 109.80M | 66.60M | 90.00M | 43.00M | 47.80M | 88.60M | 71.40M | -79.70M | 130.40M | 138.60M | 156.90M | 309.13M | 138.90M | 158.10M | 194.70M |
| EBITDA Ratio | 10.31% | 11.50% | 11.92% | 10.78% | 13.40% | 13.22% | 14.49% | 15.44% | 14.74% | 14.73% | 14.29% | 14.14% | 8.60% | 14.42% | 7.37% | 15.22% | 15.01% | 16.73% | 26.64% | 27.14% | 34.29% | 39.03% | 73.66% | 32.55% | 28.75% | 41.38% |
| Operating Income | 161.60M | 187.30M | 132.10M | 82.60M | 149.90M | 133.50M | 129.70M | 105.40M | 156.30M | 112.50M | 90.60M | 98.40M | 49.60M | 72.20M | 20.70M | 43.60M | 47.90M | 31.90M | -97.70M | 40.80M | 98.30M | 105.00M | 59.30M | 58.70M | 89.70M | 134.90M |
| Operating Income Ratio | 8.29% | 9.54% | 8.91% | 6.92% | 9.91% | 9.04% | 9.93% | 11.93% | 15.44% | 11.71% | 11.06% | 12.67% | 6.40% | 10.57% | 3.46% | 6.81% | 7.95% | 6.00% | -18.51% | 8.49% | 21.27% | 23.26% | 14.09% | 13.90% | 17.36% | 29.01% |
| Total Other Income/Expenses | 12.80M | -2.70M | 2.30M | -35.10M | 500.00K | -1.90M | -4.30M | -2.30M | -4.00M | -1.60M | 2.20M | -3.20M | 3.00M | -1.50M | -2.40M | -24.70M | -200.00K | 0.00 | -20.40M | -7.70M | -20.60M | -31.00M | -22.60M | -23.00M | -14.40M | -23.10M |
| Income Before Tax | 174.40M | 184.60M | 134.40M | 39.70M | 150.40M | 131.60M | 128.10M | 103.10M | 152.30M | 110.90M | 92.80M | 95.20M | 52.60M | 70.70M | 18.30M | 18.80M | 47.70M | 31.90M | -118.10M | 31.10M | 77.10M | 74.00M | 36.70M | 35.70M | 75.30M | 111.90M |
| Income Before Tax Ratio | 8.95% | 9.40% | 9.06% | 3.33% | 9.94% | 8.91% | 9.80% | 11.67% | 15.04% | 11.54% | 11.33% | 12.26% | 6.79% | 10.35% | 3.06% | 2.94% | 7.92% | 6.00% | -22.38% | 6.47% | 16.68% | 16.39% | 8.72% | 8.45% | 14.57% | 24.06% |
| Income Tax Expense | 35.30M | 51.60M | 41.30M | 11.00M | 38.20M | 46.60M | 66.30M | 21.80M | 32.80M | 26.80M | 15.00M | 26.90M | 3.70M | -3.00M | 11.90M | 6.30M | 18.20M | 20.40M | 4.20M | 20.00M | 23.30M | 23.00M | 19.80M | 17.40M | 32.70M | 41.50M |
| Net Income | 139.10M | 133.00M | 93.10M | 28.70M | 112.20M | 85.00M | 61.80M | 81.30M | 119.50M | 84.10M | 77.80M | 68.30M | 48.90M | 73.70M | 6.40M | 12.50M | 29.50M | 11.40M | -123.70M | 6.20M | 51.80M | 52.10M | 5.60M | 18.30M | 42.60M | 70.40M |
| Net Income Ratio | 7.14% | 6.77% | 6.28% | 2.41% | 7.41% | 5.76% | 4.73% | 9.20% | 11.80% | 8.75% | 9.50% | 8.80% | 6.31% | 10.79% | 1.07% | 1.95% | 4.90% | 2.14% | -23.44% | 1.29% | 11.21% | 11.54% | 1.33% | 4.33% | 8.24% | 15.14% |
| EPS | 5.60 | 5.37 | 3.78 | 1.17 | 4.58 | 3.48 | 2.56 | 3.39 | 4.96 | 3.45 | 3.29 | 2.89 | 2.07 | 3.10 | 0.27 | 0.53 | 1.23 | 0.47 | -5.00 | 0.25 | 2.17 | 2.21 | 0.24 | 0.73 | 1.54 | 2.42 |
| EPS Diluted | 5.56 | 5.32 | 3.75 | 1.16 | 4.54 | 3.45 | 2.52 | 3.33 | 4.86 | 3.38 | 3.22 | 2.81 | 1.99 | 2.97 | 0.26 | 0.51 | 1.19 | 0.45 | -5.00 | 0.24 | 2.06 | 2.08 | 0.23 | 0.71 | 1.53 | 2.42 |
| Weighted Avg Shares Out | 24.85M | 24.79M | 24.65M | 24.56M | 24.48M | 24.40M | 24.15M | 24.00M | 24.11M | 24.39M | 23.65M | 23.19M | 24.52M | 23.76M | 23.64M | 23.60M | 23.92M | 24.14M | 24.74M | 24.69M | 23.87M | 23.63M | 23.53M | 25.16M | 27.65M | 29.03M |
| Weighted Avg Shares Out (Dil) | 25.02M | 24.98M | 24.85M | 24.78M | 24.73M | 24.60M | 24.49M | 24.44M | 24.61M | 24.88M | 24.16M | 23.85M | 24.57M | 24.81M | 24.71M | 24.39M | 24.84M | 25.34M | 24.74M | 25.98M | 25.15M | 25.11M | 24.89M | 26.00M | 27.96M | 29.03M |
Innospec (IOSP) Expands Global Presence With QGP Acquisition
Innospec (IOSP) achieves a strategic milestone with the acquisition of QGP Quimica Geral in Brazil, enhancing its global presence and strengthening the Performance Chemicals segment.
Innospec Acquires QGP Química
ENGLEWOOD, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it completed the acquisition of QGP Química Geral (“QGP”), a leading specialty chemicals company based in Brazil. Terms of the acquisition were not disclosed.
Innospec's (IOSP) Earnings Beat Estimates in Q3, Revenues Lag
Innospec (IOSP) saw continued strong results in its Oilfield Services unit and a sequential improvement in the Performance Chemicals segment in Q3.
Innospec, Inc. (IOSP) Q3 2023 Earnings Call Transcript
Innospec, Inc. (IOSP) Q3 2023 Earnings Call Transcript
Innospec Reports Third Quarter 2023 Financial Results
Strong sequential improvement in Performance Chemicals; Continued excellent results in Oilfield Services; Consistent performance in Fuel Specialties
Innospec (IOSP) Expected to Beat Earnings Estimates: Should You Buy?
Innospec (IOSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Innospec (IOSP) Could Beat Earnings Estimates Again
Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Innospec Schedules Third Quarter 2023 Earnings Release and Conference Call
ENGLEWOOD, Colo., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2023 earnings results on Tuesday, November 7, 2023 after market close.
Innospec Publishes 2022 ESG Report
ENGLEWOOD, Colo., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Innospec (NASDAQ: IOSP) today announced the publication of its 2022 ESG Report. The report provides an overview of the company's progress and ongoing commitment to ESG and sustainability.
Innospec's (IOSP) Earnings Beat Estimates in Q2, Revenues Lag
Strong results in Innospec's (IOSP) Oilfield Services unit were partly offset by the weakness in the Performance Chemicals segment in Q2.
Source: https://incomestatements.info
Category: Stock Reports